Researchers from MIT and other institutions uncovered the use of a “prized synthetic pigment imported from ancient Egypt” that was used to paint the walls of a home in ancient Pompeii, reports James Imam for The Times. “The quality of the decoration is unbelievable… It’s very rare, even unique, to find a completely blue sacrarium,” says Prof. Admir Masic. “These owners were really very, very wealthy.”
Graduate student Verena Bellscheidt has been awarded the Zonta Club of Wuaboag Valley Women in STEM award, reports The Republican. Bellscheidt is “dedicated to advancing the field [of theoretical physics] at the intersection of cosmology and particle physics while mentoring the next generation of female scientists.”
Researchers at MIT have developed an “AI-driven optimization method that works like ‘ChatGPT for spreadsheets’ – a tabular foundation model designed to handle spreadsheet-style data common in engineering design problems,” reports Gene Marks for Forbes. “The AI system identifies which design variables matter most and focuses search efforts on those, making problem solving less cumbersome,” writes Marks.
Prof. Alessandro Acquisti speaks with WBUR reporters Woodrow Hartzog and Neil Richards about privacy concerns surrounding consumer data. “The online advertising industry has long extolled the benefits of targeted advertising, presenting it as an economic win-win for publishers, merchants and consumers alike,” says Acquisti. “And yet, in reality, there is little robust empirical evidence that any stakeholder – other than the data intermediaries themselves – actually benefit from this type of advertising.”
Researchers at MIT have developed “mini livers” that “can be injected into the body to help take over the functions of a failing liver,” reports Ian Randall for Newsweek. “If realized clinically, the development could provide a lifeline for many of the more than 10,000 Americans with chronic liver disease currently waiting for a transplant,” writes Randall.
The Advanced Research Projects Agency for Health (ARPA-H) is providing funding for the Ocular Laboratory for Analysis of Biomarkers (OCULAB), which includes researchers from MIT and "will initially focus on dry eye disease that affects more than 20 million people in the United States,” reports Alison Kuznitz at State House News Service. The MIT team is "building sensors to detect biomarkers of dry eye disease and diabetes,” writes Kuznitz.
A study by Prof. Taha Choukhmane and his colleagues has found that “by switching retirement contributions to the account with the higher match rate, 1 in 5 couples could increase their savings by an estimated $750 per year,” reports Lorie Konish for CNBC. “The absence of coordination can be a choice, but it’s a costly choice,” says Choukhmane.
MIT researchers have “achieved a breakthrough towards building scalable quantum computers,” reports Prabhat Ranjan Mishra for Interesting Engineering, using “cryoelectronics to control ion traps, a key step toward realizing scalable quantum computers.” The team says “this proof-of-principle experiment marks an important advancement toward building large-scale ion-trap quantum computing systems,” writes Mishra.
Prof. Robert Langer, Prof. Giovanni Traverso and former postdoctoral fellow Thomas von Erlach founded Vivtex, a biotechnology startup that has “created a high-tech system called a ‘GI tract on a chip’ that uses robotics and AI to test how drugs move through the human digestive system,” reports Beth Treffeisen for Boston.com. “The technology allows Vivtex to quickly test thousands of drug formulations and predict how they will be absorbed in people, much more accurately than traditional lab methods.”
A study by researchers at MIT has found that high levels of greenhouse gas emissions in the atmosphere is impacting the satellite orbits that typically force objects back to Earth, leading to an increased amount of space junk, reports Sachi Kitajima Mulkey for The New York Times. “[W]e’re losing this cleaning force that we rely on” says William Parker PhD '25.
Profs. Robert Langer, Giovanni Traverso and former postdoctoral fellow Thomas von Erlach have founded Vivtex, a biotechnology startup specializing in “oral alternatives to drugs administered by injections,” reports Jonathan Satlzman for The Boston Globe. Vivtex, now working in collaboration with Novo Nordisk, is looking to develop a new class of “pills to treat obesity and diabetes,” explains Saltzman.
A paper by Prof. Christopher Knittel and his colleagues explores the impact of climate change on inflation, reports Lydia DePillis for The New York Times. “We’re likely at this inflection point where costs are going to start growing more rapidly,” says Knittel. “The observed costs have been fairly linear so far. Going forward, that’s going to start increasing at an increasing rate.”
MIT researchers have built “the first complete model of pedestrian activity in New York City,” a template that could be applied to any U.S. city, reports Elissaveta M. Brandon for Fast Company. “The model, which maps foot traffic across all sidewalks, crosswalks and footpaths in NYC during peak periods, reveals surprising patterns about the way people move around the city, as well as where they are most vulnerable to vehicle crashes,” explains Brandon. “It could have tremendous benefits for city planners.”
Prof. Daron Acemoglu speaks with Fortune reporter Jake Angelo about his work studying the “origins of economic and political decay,” and the need for the U.S. to crack down “on economic inequality and tempering with job destruction.” “If we go down this path of destroying jobs [and] creating more inequality, U.S. democracy is not going to survive,” says Acemoglu.
A working paper by Prof. Jonathan Gruber and his colleagues has found “that admitting more immigrations would help save the lives of Americans, particularly seniors,” reports Stuart Anderson for Forbes.